ArticleScience progress
Prognostic significance of the neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI) and panimmune-inflammation value (PIV) in head and neck squamous cell carcinoma (HNSCC): A retrospective cohort study.
Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Preoperative Systemic Inflammatory Marker Profile in Surgically Treated Intradural Spinal Tumors: A Retrospective Cohort Study.Medicina (Kaunas, Lithuania) · 2026Article
- Diagnostic value of the pan-immune-inflammation value, plateletcrit, and monocyte count in salivary gland tumors: a 10-year two-stage retrospective analysis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026Article
- Additional predictive value of systemic inflammation indices beyond prostate specific antigen density for clinically significant prostate cancer.BMC urology · 2026Article
- Potential Diagnostic and Prognostic Value of Neutrophil Counts, Neutrophil-Lymphocyte Ratio, Pan-Immunoinflammatory Score, Systemic Immunoinflammatory Index, and Systemic Inflammatory Response Index in Brain Tumors.Diagnostics (Basel, Switzerland) · 2026Article
- Systemic Inflammatory Indices and Disease Severity in Acute Colonic Pseudo-Obstruction: An Exploratory Retrospective Study.Diagnostics (Basel, Switzerland) · 2026Article
- Cumulative inflammatory, coagulation, and metabolic abnormalities predict poor 90-day functional outcome after endovascular thrombectomy for large-vessel occlusion acute ischemic stroke.Frontiers in neurology · 2026Article
- Preoperative differentiation of acute appendicitis using NLR, SII, and maximum appendiceal diameter: a retrospective single-center diagnostic study.Frontiers in surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveInflammatory markers, such as the neutrophil-to-lymphocyte Ratio (NLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and panimmune-inflammatory value (PIV), have previously been identified as prognostic factors in head and neck cancer (HNC). Notably, time-dependent receiver operating characteristic (ROC) curves have rarely been used to assess the prognostic role of inflammatory markers in head and neck cancer. This study aimed to evaluate the significance of the NLR, SII, SIRI, and PIV in this context.MethodsThis retrospective cohort study was conducted at Far Eastern Memorial Hospital, a tertiary medical center between July 2022 and January 2025, and 153 patients with HNC were enrolled in this study. Inflammatory markers were compared by tumor status, nodal involvement, and stage. Time-dependent ROC analysis was used to determine the area under the curve (AUC) and optimal cutoff values for overall survival (OS) and disease-specific survival (DSS) with Cox regression.ResultsThe NLR, SII, SIRI, and PIV were significantly associated with tumor status and stage (p < 0.05). The optimal cutoff values were 2.9, 630, 1.6, and 400, with corresponding time-dependent AUCs of 0.73, 0.71, 0.64, and 0.62, with corresponding sensitivities of 81.7%, 81.2%, 55.9%, and 60.8%, and specificities of 64.1%, 54.9%, 68.5%, and 60.4%., respectively. Higher NLR, SII, SIRI, and PIV values were associated with poor OS and DSS.ConclusionsThe NLR, SII, SIRI, and PIV are associated with tumor status and poor survival outcomes (OS and DSS) and may provide additional stratification and risk-based management in patients with HNC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.